 |
ImmunOs Therapeutics
Last updated: October 10, 2024
Founder Osiris Marroquin Belaunzaran
Switzerland | Funding: $101.8M (+)
Website: https://www.immunostherapeutics.com
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Website: https://www.immunostherapeutics.com
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
